Ruling of the Tribunal regarding the CMA’s application for costs. The Tribunal decided the appellants’ respective liability for the CMA’s costs.
All the appellants are jointly and severally liable for 80% of 85% (i.e. 68%) of the CMA’s costs and GSK is liable for 50% of 15% (i.e. 7.5%) of the CMA’s costs. The Tribunal also ruled that the CMA should recover 90% of the additional costs of its submissions on costs from all the appellants.
All the costs will be subject to a detailed assessment by a Costs Judge of the Senior Courts of England and Wales, unless agreed.
This is an unofficial summary prepared by the Registry of the Competition Appeal Tribunal.